Search Results - "drug development"

Anticancer efficacy and absorption, distribution, metabolism, and toxicity studies of Aspergiolide A in early drug development by Wang Y, Qi X, Li D, Zhu T, Mo X, Li J

Connect to this object online.

Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development by Wei Gao, Jiang Liu, Blerta Shtylla, Karthik Venkatakrishnan, Donghua Yin, Mirat Shah, Timothy Nicholas, Yanguang Cao

Connect to this object online.

Mapping current trends in 3D printing and the impact on the recent landscape of drug development research by Craig Russell, Harriet Hampshire

Connect to this object online.

Current state and future of 3D bioprinted models for cardio-vascular research and drug development by Liudmila Polonchuk, Carmine Gentile

Connect to this object online.

Breast Cancer: a Global Concern, Diagnostic and Therapeutic Perspectives, Mechanistic Targets in Drug Development by Gul-, Rehmat Jan, Abdah Akim, Muhammad Naveed Zafar, Yeong Yik Sung, Tengku Sifzizul Tengku Muhammad

Connect to this object online.

Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development by Dion R. Brocks, Neal M Davies

Connect to this object online.

Nuclear Receptors as Targets for Drug Development: Regulation of Cholesterol and Bile Acid Metabolism by Nuclear Receptors by Makoto Makishima

Connect to this object online.

Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development by Ana Victoria Ponce‐Bobadilla, Vanessa Schmitt, Corinna S. Maier, Sven Mensing, Sven Stodtmann

Connect to this object online.

Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model by Arundhati Maitra, Priya Solanki, Zahra Sadouki, Timothy D. McHugh, Frank Kloprogge

Connect to this object online.

N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development by Yi Niu, Arabella Wan, Ziyou Lin, Xiongbin Lu, Guohui Wan

Connect to this object online.

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making by Robbe Saesen, Robbe Saesen, Stéphane Lejeune, Gianluca Quaglio, Denis Lacombe, Isabelle Huys

Connect to this object online.

Book Review: Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer by Dipesh Dhakal, Yogesh Dhakal, Jae K. Sohng, Jae K. Sohng

Connect to this object online.

Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment by Yusuf Muhammed

Connect to this object online.

Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children by Katharine Cheng, Fenna Mahler, Irja Lutsar, Begonya Nafria Escalera, Stefanie Breitenstein, Gilles Vassal, Joana Claverol, Nuria Noel Palacio, Ron Portman, Gavin Pope, Martijn Bakker, Tessa van derGeest, Mark A. Turner, Saskia N. deWildt, c4c Expert Group Leads

Connect to this object online.

Modality diversification and best-in-class small-molecule drugs: Recent trend of orphan drug development by Ryo Okuyama

Connect to this object online.

The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development Teams by Sandor Kerpel-Fronius, Sander Becker, Jane Barrett, Johan Brun, Roberto Carlesi, Anthony Chan, Luis F. Collia, Dominique J. Dubois, Peter Kleist, Greg Koski, Chieko Kurihara, Luis F. Laranjeira, Johanna Schenk, Honorio Silva

Connect to this object online.

Prediction of Positions of Active Compounds Makes It Possible To Increase Activity in Fragment-Based Drug Development by Yoshifumi Fukunishi

Connect to this object online.

3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development by Andrei Molotkov, Mikhail Doubrovin, Nikunj Bhatt, Fang-Chi Hsu, Amanda Beserra, Rajiv Chopra, Akiva Mintz

Connect to this object online.

Pathophysiological Significance of T-type Ca2+ Channels: T-type Ca2+ Channels and Drug Development by Hikaru Tanaka, Koki Shigenobu

Connect to this object online.

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing by Wei-Yang Chen, Eric A Evangelista, Jade Yang, Edward J Kelly, Edward J Kelly, Catherine K Yeung, Catherine K Yeung

Connect to this object online.